Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Highlights

Highlights October 9, 2013 Volume 310, Number 14 In This Issue of JAMA Pages 1417-1520 Opinion Research Viewpoint SLN Surgery After Neoadjuvant Chemotherapy in Breast Cancer 1455 1441 The 3-Night Hospital Stay The clinical utility of sentinel lymph node (SLN) surgery for staging the axilla after and Medicare Coverage for Skilled neoadjuvant chemotherapy in node-positive breast cancer is unclear. In a clinical trial that Nursing Care enrolled 663 women who presented with biopsy-proven node-positive breast cancer, LA Lipsitz received neoadjuvant chemotherapy, and then underwent SLN surgery and axillary lymph 1443 The Future of the Medicare Home node dissection, Boughey and colleagues found that the false-negative rate of SLN surgery Health Program S Landers exceeded an acceptability threshold of 10%. In an Editorial, Morrow and Dang discuss SLN surgery after neoadjuvant chemotherapy for breast cancer. 1445 Empowering Patients Who Have Specific Learning Disabilities Related Editorial 1449 LN Rossignol and MK Paasche-Orlow Cardiac Events After Noncardiac Surgery in Patients With Stents 1462 A Piece of My Mind Current guidelines recommend that noncardiac surgery be delayed after coronary stent 1447 As If He Were Family AB Possner placement—6 weeks’ delay for patients with bare metal stents and a year delay for those with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Highlights

JAMA , Volume 310 (14) – Oct 9, 2013
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/highlights-2IEr6TpACo

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2013.5351
Publisher site
See Article on Publisher Site

Abstract

October 9, 2013 Volume 310, Number 14 In This Issue of JAMA Pages 1417-1520 Opinion Research Viewpoint SLN Surgery After Neoadjuvant Chemotherapy in Breast Cancer 1455 1441 The 3-Night Hospital Stay The clinical utility of sentinel lymph node (SLN) surgery for staging the axilla after and Medicare Coverage for Skilled neoadjuvant chemotherapy in node-positive breast cancer is unclear. In a clinical trial that Nursing Care enrolled 663 women who presented with biopsy-proven node-positive breast cancer, LA Lipsitz received neoadjuvant chemotherapy, and then underwent SLN surgery and axillary lymph 1443 The Future of the Medicare Home node dissection, Boughey and colleagues found that the false-negative rate of SLN surgery Health Program S Landers exceeded an acceptability threshold of 10%. In an Editorial, Morrow and Dang discuss SLN surgery after neoadjuvant chemotherapy for breast cancer. 1445 Empowering Patients Who Have Specific Learning Disabilities Related Editorial 1449 LN Rossignol and MK Paasche-Orlow Cardiac Events After Noncardiac Surgery in Patients With Stents 1462 A Piece of My Mind Current guidelines recommend that noncardiac surgery be delayed after coronary stent 1447 As If He Were Family AB Possner placement—6 weeks’ delay for patients with bare metal stents and a year delay for those with

Journal

JAMA – American Medical Association

Published: Oct 9, 2013

There are no references for this article.